MPS IIIB

Clinical trials for MPS IIIB explained in plain language.

Never miss a new study

Get alerted when new MPS IIIB trials appear

Sign up with your email to follow new studies for MPS IIIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Hope for kids with rare brain disease: new drug trial launches

Disease control Not yet recruiting

This study tests a new drug called tralesinidase alfa for children aged 1 to 5 with Sanfilippo syndrome type B, a rare genetic disease that damages the brain. The drug is given directly into the fluid around the brain and aims to slow down thinking and learning problems. About 14…

Matched conditions: MPS IIIB

Phase: PHASE3 • Sponsor: Spruce Biosciences • Aim: Disease control

Last updated May 26, 2026 10:55 UTC

MPS IIIB

Get alerted when new MPS IIIB trials appear

Hope for kids with rare brain disease: new drug trial launches